Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-000103
Filing Date
2025-01-02
Accepted
2025-01-02 16:32:09
Documents
2
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 form3-01022025_090106.html 3  
1 form3-01022025_090106.xml 3 12302
2 ex24-01022025_090109.htm EX-24 5249
  Complete submission text file 0001415889-25-000103.txt   18969
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Issuer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARATANA THERAPEUTICS, INC. 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address
HELLUMS RHONDA LYNETTE (Reporting) CIK: 0001766456 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39487 | Film No.: 25502506